209 related articles for article (PubMed ID: 36933381)
1. Metabolic reprogramming and interventions in endometrial carcinoma.
Li J; Yang H; Zhang L; Zhang S; Dai Y
Biomed Pharmacother; 2023 May; 161():114526. PubMed ID: 36933381
[TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming in epithelial ovarian cancer.
Nantasupha C; Thonusin C; Charoenkwan K; Chattipakorn S; Chattipakorn N
Am J Transl Res; 2021; 13(9):9950-9973. PubMed ID: 34650675
[TBL] [Abstract][Full Text] [Related]
3. Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer.
Huang P; Fan X; Yu H; Zhang K; Li H; Wang Y; Xue F
J Transl Med; 2023 Feb; 21(1):94. PubMed ID: 36750868
[TBL] [Abstract][Full Text] [Related]
4. Nutrient deprivation-related OXPHOS/glycolysis interconversion via HIF-1α/C-MYC pathway in U251 cells.
Liu Z; Sun Y; Tan S; Liu L; Hu S; Huo H; Li M; Cui Q; Yu M
Tumour Biol; 2016 May; 37(5):6661-71. PubMed ID: 26646563
[TBL] [Abstract][Full Text] [Related]
5. Targeting Cancer Metabolism Plasticity with JX06 Nanoparticles via Inhibiting PDK1 Combined with Metformin for Endometrial Cancer Patients with Diabetes.
Yang X; Cheng Y; Zhou J; Zhang L; Li X; Wang Z; Yin S; Zhai L; Huang T; Wu X; Shen B; Dong Y; Zhao L; Chi Y; Jia Y; Wang J; He Y; Dong X; Xiao H; Wang J
Adv Sci (Weinh); 2022 Mar; 9(8):e2104472. PubMed ID: 35064767
[TBL] [Abstract][Full Text] [Related]
6. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
Lu J; Tan M; Cai Q
Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells.
Li X; Han G; Li X; Kan Q; Fan Z; Li Y; Ji Y; Zhao J; Zhang M; Grigalavicius M; Berge V; Goscinski MA; Nesland JM; Suo Z
Oncotarget; 2017 Jul; 8(28):46363-46380. PubMed ID: 28624784
[TBL] [Abstract][Full Text] [Related]
8. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
Yoshida GJ
J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
[TBL] [Abstract][Full Text] [Related]
9. Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States.
Jia D; Park JH; Jung KH; Levine H; Kaipparettu BA
Cells; 2018 Mar; 7(3):. PubMed ID: 29534029
[TBL] [Abstract][Full Text] [Related]
10. LIN28B induced PCAT5 promotes endometrial cancer progression and glycolysis via IGF2BP3 deubiquitination.
Wang B; Wang B; Ma J; He JJ; Wang ZH; Li Q; Ma XX
Cell Death Dis; 2024 Apr; 15(4):242. PubMed ID: 38565547
[TBL] [Abstract][Full Text] [Related]
11. Multifaceted roles of aerobic glycolysis and oxidative phosphorylation in hepatocellular carcinoma.
Zhang Y; Li W; Bian Y; Li Y; Cong L
PeerJ; 2023; 11():e14797. PubMed ID: 36748090
[TBL] [Abstract][Full Text] [Related]
12. Juglone promotes antitumor activity against prostate cancer via suppressing glycolysis and oxidative phosphorylation.
Hu C; Xu H; Li Z; Liu D; Zhang S; Fang F; Wang L
Phytother Res; 2023 Feb; 37(2):515-526. PubMed ID: 36281060
[TBL] [Abstract][Full Text] [Related]
13. OMA1 reprograms metabolism under hypoxia to promote colorectal cancer development.
Wu Z; Zuo M; Zeng L; Cui K; Liu B; Yan C; Chen L; Dong J; Shangguan F; Hu W; He H; Lu B; Song Z
EMBO Rep; 2021 Jan; 22(1):e50827. PubMed ID: 33314701
[TBL] [Abstract][Full Text] [Related]
14. The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes.
Li N; Zhan X; Zhan X
Gynecol Oncol; 2018 Aug; 150(2):343-354. PubMed ID: 29921511
[TBL] [Abstract][Full Text] [Related]
15. An Overview: The Diversified Role of Mitochondria in Cancer Metabolism.
Liu Y; Sun Y; Guo Y; Shi X; Chen X; Feng W; Wu LL; Zhang J; Yu S; Wang Y; Shi Y
Int J Biol Sci; 2023; 19(3):897-915. PubMed ID: 36778129
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine.
Li N; Li H; Wang Y; Cao L; Zhan X
EPMA J; 2020 Dec; 11(4):661-694. PubMed ID: 33240452
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial and metabolic alterations in cancer cells.
Di Gregorio J; Petricca S; Iorio R; Toniato E; Flati V
Eur J Cell Biol; 2022; 101(3):151225. PubMed ID: 35453093
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links.
Wang Y; Zeng X; Tan J; Xu Y; Yi C
Medicine (Baltimore); 2022 Aug; 101(34):e30299. PubMed ID: 36042597
[TBL] [Abstract][Full Text] [Related]
19. Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.
Jia D; Lu M; Jung KH; Park JH; Yu L; Onuchic JN; Kaipparettu BA; Levine H
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3909-3918. PubMed ID: 30733294
[TBL] [Abstract][Full Text] [Related]
20. Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells.
Ippolito L; Marini A; Cavallini L; Morandi A; Pietrovito L; Pintus G; Giannoni E; Schrader T; Puhr M; Chiarugi P; Taddei ML
Oncotarget; 2016 Sep; 7(38):61890-61904. PubMed ID: 27542265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
